NCT06488716 2025-12-24
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
Genentech, Inc.
Phase 1 Terminated
Genentech, Inc.
AstraZeneca
AstraZeneca
Maastricht Radiation Oncology
Kyowa Kirin Co., Ltd.
CrystalGenomics, Inc.
Nerviano Medical Sciences